ARQT Arcutis Biotherapeutics, Inc.
$23.89▲ +2.16%
Healthcare
Other
After hours
$23.89▲ +0.00%
Sep 11, 7:30 PM ET
Volume 2.04M
Avg Volume (10D) 1.97M
Key Metrics & Fundamentals
Market Cap
$3.00B
P/E Ratio
108.6
Div Yield
–%
52W Range
16.57 - 31.77
% vs 50 MA
-8.71%
% vs 200 MA
-6.41%
RSI-14
41.6
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.14
Free Cash Flow
$12.48M
Gross Rev
$129.86M
Gross Profit
$118.92M
EBITDA
$19.11M
COGS
$10.94M
Operating Exp
$102.49M
Operating Income
$16.43M
EBIT
$16.43M
Pretax Income
$15.15M
Net Income
$15.01M
EPS (Diluted)
0.11
Price & Volume History
Loading chart…
Recent News

Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
PR Newswire · Sep 4, 2026 11:15 PM

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 8:00 PM

Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 8:00 PM

Here's Why You Should Add ARQT Stock to Your Portfolio Now
Zacks · Aug 28, 2026 2:58 PM

Arcutis Biotherapeutics (ARQT) Faces A Valuation Test, Is It Still A Bargain?
Simply Wall St. · Aug 28, 2026 1:07 AM

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
Zacks · Aug 27, 2026 8:27 AM

5 Biotech Stocks Worth Adding to Your Portfolio Now
Zacks · Aug 26, 2026 2:19 PM
Oruka Therapeutics Names Chief Commercial Officer
MT Newswires · Aug 24, 2026 8:14 PM

Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
GlobeNewswire · Aug 24, 2026 8:01 PM
Arcutis Biotherapeutics' Zoryve Gets Health Canada Approval for Children With Atopic Dermatitis
MT Newswires · Aug 20, 2026 5:55 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARQT's money flow as a full page
Social Sentiment
Avg +0.75 · 4 posts
DDNews$ARQT - recent performance trial successes
r/wallstreetbets · Apr 3, 2025
Positive trial results and FDA submission suggest potential stock performance improvement.
positive
+0.80
$ARQT – This Skincare Stock looks like it’s About to “Glow” TF Up… Anyone somewhat versed in biotech have a take on this?
r/stocks · Mar 27, 2025
The post demonstrates strong bullish sentiment due to significant gains, insider buying, and positive trial data, suggesting potential for further growth.
positive
+0.70
DDNewsDiscussion$ARQT – The Skincare Stock That’s About to “Glow” TF Up🧨📈
r/wallstreetbets · Mar 27, 2025
very_positive
+0.90
DDTradeNewsARQT DD
r/wallstreetbets · Nov 29, 2024
The user's purchase decision driven by a promising product announcement indicates a positive sentiment towards ARQT.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.